Mycetoma on a neoformed cavity
DOI:
https://doi.org/10.35954/SM2018.37.2.8Keywords:
Aspergillus flavus, Lung Diseases, Fungal, MycetomaAbstract
It is reported a case of pulmonary aspergillosis, under the presentation of a pulmonary mycetoma, isolated as agent Aspergillus Flavus; it was attended in the medicine ward and Pulmonology Service of the Armed Forces Central Hospital of Uruguay.The patient had a post-infections sequela cavity in the same lung where he had shown a bronchopulmonary carcinoma stage IIIB, assisted with chemotherapy and radiotherapy in the previous year.
Downloads
References
(1) Detterbeck FC1, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. Chest 2017; 151(1):193-203. doi: 10.1016/j.chest.2016.10.0108.
(2) Muldoon EG, Strek ME, Patterson KC. Allergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes. Clin Chest Med 2017; 38(3):521-534.
(3) Walicka-Serzysko K, Sands D. The clinical pre-sentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Dev Period Med 2015; 19(1):66-79.
(4) Lopes Ruiz Júnior R, Sobral de Oliveira F, Burgos Piotto B, Lopez Muniz F, Cataneo D, Cataneo A. Surgical treatment of pulmonary aspergilloma. J Bras Pneumol 2010; 36(6):779-783.
(5) Dos Santos Marsico Pereira Da Silva P, Marsico G, Ferraz Araujo M, Soares Vannucci Braz F, Teixeira Andrade dos Santos H, Loureiro G, Fontes A.Complex pulmonary aspergilloma treated by cavernostomy. Rev Col Bras Cir 2014; 41(6): 406-411.doi: 10.1590/0100-69912014006005.
(6) Thompson GR 3rd, Patterson TF. Pulmonary aspergillosis: recent advances. SeminRespirCrit Care Med 2011; 32(6):673-81. doi: 10.1055/s-0031-1295715.
(7) Kasprzyk M, Pieczyński K, Mania K, Gabryel P, Piwkowski C, Dyszkiewicz W. Surgical treatment for pulmonary aspergilloma - early and long-term results. Kardiochir Torakochirurgia Pol 2017; 14(2):99-103. doi: 10.5114/kitp.2017.68738.
(8) Oakley R, Petrou M, Goldstraw P . Indications and outcome of surgery for pulmonary aspergilloma. Thorax 1997; 52(9):813-5.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
